Acquired CD74-ROS1 fusion-mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case report.


Güren A. K., Kocaaslan E., Ağyol Y., Erel P., Paçacı B., Tunç M. A., ...Daha Fazla

Journal of chemotherapy (Florence, Italy), ss.1-5, 2026 (SCI-Expanded, Scopus) identifier